Clinical Research Directory
Browse clinical research sites, groups, and studies.
Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis
Sponsor: University of Child Health Sciences and Children's Hospital, Lahore
Summary
This open labelled randomized controlled trial will be carried out at the University of Child Health and the Children's Hospital, Lahore consisting of 6 months . In total 60 patients (30 in each group) fulfilling the inclusion criteria will be selected and enrolled in this study. Patients will be divided into two groups; Group A (Injection Etanercept+ Tab methotrexate) and Group B (Injection Etanercept+ Tab methotrexate). Data will be collected at baseline, 1,3 and 6 months. Data will be collected and recorded
Official title: Response of Methotrexate Alone Versus Methotrexate Combined With Etanercept for Achieving Minimal/Low Disease Activity in Patients of Juvenile Idiopathic Arthritis
Key Details
Gender
All
Age Range
2 Years - 16 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-01-27
Completion Date
2026-07-27
Last Updated
2026-02-04
Healthy Volunteers
Yes
Conditions
Interventions
Injection, Etanercept, 25 Mg (Code May Be Used for Medicare When Drug Administered Under the Direct Supervision of A Physician, Not for Use When Drug is Self Administered)
Injection Etanercept is biological TNF Inhibitor.
Locations (1)
University of Child Health Sciences Lahore, The Children's hospital Lahore
Lahore, Punjab Province, Pakistan